Context Capital Management »

Ani Pharmaceuticals shares owned by Context Capital Management

Quarter-by-quarter ownership of Ani Pharmaceuticals shares owned by Context Capital Management from 13F filings

Historical chart of Context Capital Management investment in Ani Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ani Pharmaceuticals held by Context Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ani Pharmaceuticals by Context Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $13M 10M 1.26

More positions owned by Context Capital Management

Strategy Note 12/0 (Principal)
Echostar Corp Note 3.875%11/3 (Principal)
Peloton Interactive Note 5.500%12/0 (Principal)
Mara Holdings Note 6/0 (Principal)
Conmed Corp Note 2.250% 6/1 (Principal)
Teladoc Health Note 1.250% 6/0 (Principal)
Fluence Energy Note 2.250% 6/1 (Principal)
Bridgebio Pharma Note 2.250% 2/0 (Principal)
Super Micro Computer Note 3.500% 3/0 (Principal)
Tandem Diabetes Care Note 1.500% 3/1 (Principal)
Travere Therapeutics Note 2.250% 3/0 (Principal)
Cleanspark Note 6/1 (Principal)
Enovis Corporation Note 3.875%10/1 (Principal)
Pennymac Corp Note 8.500% 6/0 (Principal)
Century Alum Note 2.750% 5/0 (Principal)

View all positions for Context Capital Management

Top funds holding Ani Pharmaceuticals

Camden Asset Management
Alberta Investment Management Corporation
Empyrean Capital Partners
Millennium Management
Citadel Advisors
Absolute Investment Advisers
BlackRock
Context Capital Management
Jpmorgan Chase & Co
Leucadia National Corporation
Point72 Asset Management
Polar Securities
Universal- Beteiligungs- und Servicegesellschaft mbH
Gabelli Funds
Susquehanna Advisors Group

View all funds holding Ani Pharmaceuticals